Heron Therapeutics is trading at $0.35, down 5.24% on October 6, 2026, with biotech-sector weakness the strongest available context.
- XBI was down 2.50% during the session amid negative industry sentiment.
- No fresh company-specific announcement explaining the decline appeared in available search results; the latest company releases listed were dated September 29.
- Major U.S. indexes were higher, so the decline was not tracking the broader market rally.